PlGF levels did not significantly vary according to anti-RNA polymerase III antibody status among patients with SSc-SRC+ (PlGF median [IQR] levels at 43 [22–50] pg/ml among antibody negative patients, and 29 [21–44] pg/ml among antibody-positive patients). Here, SRC is linked to systemic sclerosis.